Back

Soluble transferrin receptor as a marker of tissue iron deficiency: impact on clinical outcomes in patients with heart failure without systemic iron deficiency or anaemia

27 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Comorbidities and heart failure: cause and effect Comorbidities ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Lidia Alcoberro

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

7 More presentations in this session

Presentation thumbnail
Differential effects of heart failure with reduced ejection fraction on locomotor and respiratory muscles
Doctor N. Mangner (Dresden, DE)
Abstract Slides Video
Presentation thumbnail
Short term effect of sodium glucose cotransporter 2 inhibitors and sacubitril/valsartan on comprehensive geriatric assessment and oxidative stress in elderly with chronic heart failure (from MAGIC-HF)
Doctor G. Armentaro (Catanzaro, IT)
Abstract Slides Video
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on exercise capacity and functional class in patients with heart failure without systemic iron deficiency or anaemia
Doctor P. Moliner (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on health-related quality of life in patients with heart failure without systemic iron deficiency or anaemia
Doctor P. Moliner (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Physical capacity determines physical and mental health in patients with chronic heart failure - a case control study
Mr S. Winter (Graz, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities and heart failure: cause and effect

The Event

Event poster

ESC Congress 2023

27 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on cardiac, systemic, hematinic and neurohormonal biomarkers in patients with heart failure without systemic iron deficiency
thumbnail
Congress Presentation
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on clinical outcomes in patients with heart failure without systemic iron deficiency or anaemia
thumbnail
Congress Presentation
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on exercise capacity and functional class in patients with heart failure without systemic iron deficiency or anaemia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources